Cipla BioTec Pvt. Ltd.
Quick facts
Phase 3 pipeline
- CBT124 · unknown
CBT124 is a small molecule that targets the molecular target. - EU-sourced Avastin® · Oncology
Avastin (bevacizumab) is a monoclonal antibody that blocks vascular endothelial growth factor (VEGF), preventing tumor blood vessel formation and starving tumors of oxygen and nutrients.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Cipla BioTec Pvt. Ltd.
What is Cipla BioTec Pvt. Ltd.'s pipeline?
Cipla BioTec Pvt. Ltd. has 2 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include CBT124, EU-sourced Avastin®.
Related
- Sector hub: All tracked pharma companies